Inovio Pharma (INO) Misses Q1 EPS by 4c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Epidemic response group to invest up to $384 mln in Novavax's COVID-19 vaccine
May 11, 2020 4:07 PM EDT(Reuters) - The Coalition for Epidemic Preparedness Innovations (CEPI) will invest up to $384 million to help develop and produce Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine candidate, the company said on Monday, sending its shares up 31.2% in extended trading.
CEPI, which was set up to fight emerging epidemics, said in March it would invest... More
Inovio Pharmaceuticals (INO) PT Raised to $9 at RBC Capital
May 7, 2020 6:14 AM EDTRBC Capital analyst Gregory Renza raised the price target on Inovio Pharmaceuticals (NASDAQ: INO) to $9.00 (from $7.00) while maintaining a Sector Perform rating.... More
